Biopharmaceutical company Lay Line Genomics has reached an exclusive licensing agreement with Dutch biotech group PanGenetics for the development of the antibody Hu-alphaD11, a product with similar analgesic properties to those of morphine but less agressive to the human body.
Fund invests equity tickets in the range of €200m-1bn in North American and European companies
Freight service makes its second bolt-on of 2020, having acquired Nova Traffic in May
Clinics will operate under MVZ Meine Gynäkologie Lüdenscheid, a Meine Radiologie Holding subsidiary
GP is deploying capital from its second fund, which closed in 2017 on €600m